99% Savings - Buy Just @1 Rs X
Telmiduce AM is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Telmiduce AM safe for pregnant women?
Telmiduce AM shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Telmiduce AM safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Telmiduce AM for breastfeeding women are not known.
What is the effect of Telmiduce AM on the Kidneys?
There can be some harmful effects on your kidneys after taking Telmiduce AM. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Telmiduce AM on the Liver?
There may be an adverse effect on the liver after taking Telmiduce AM. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Telmiduce AM on the Heart?
Telmiduce AM is completely safe for the heart.
Telmiduce AM should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Telmiduce AM unless your doctor advises you to do so -
Is this Telmiduce AM habit forming or addictive?
Forming a habit of Telmiduce AM has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Telmiduce AM since it does not cause drowsiness.
Is it safe?
Yes, but take Telmiduce AM only as per medical advice.
Is it able to treat mental disorders?
No, Telmiduce AM cannot treat any kind of mental disorder.
Interaction between Food and Telmiduce AM
Due to the absence of research, it is difficult to say how Telmiduce AM and food will interact.
Interaction between Alcohol and Telmiduce AM
Taking Telmiduce AM and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
Telmiduce AM is available in the form of tablets. A tablet is usually taken once a day, with or without food because food affects the absorption of this drug. It should be taken at exactly the same time every time to avoid skipping the dose. Telmiduce AM might start showing the effects between 2 to 4 weeks, therefore, it is important to continue taking it even when you feel well. One should take Telmiduce AM exactly as prescribed by their doctor.
No, Telmiduce AM is not a beta blocker/calcium channel blocker/diuretic/blood thinner/ace inhibitor. It is angiotensin II receptor blocker (an antihypertensive drug).
Telmiduce AM is the brand name for telmisartan. It belongs to a group of medications known as angiotensin II receptor blockers. It is available in the form of tablets. Telmiduce AM is used to treat hypertension. It is also used to decrease cardiovascular risk in patients who cannot take ACE (angiotensin-converting enzyme) inhibitors.
No, Telmiduce AM does not cause weight gain. Weight gain has rarely been associated with this drug. However, if you are experiencing unusual weight gain and you are in doubt that Telmiduce AM is causing weight gain then discuss with your doctor instantly.
Telmiduce AM contains telmisartan which is an antihypertensive drug that works by preventing a chemical (angiotensin II) to bind with a receptor. This causes relaxation of blood vessels, it also prevents the synthesis and release of aldosterone (a hormone whose hyperactivity results in high blood pressure). In this way Telmiduce AM decreases the blood pressure.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148